Sansure Biotech Inc (688289) - Total Liabilities

Latest as of June 2026: CN¥2.56 Billion CNY ≈ $374.89 Million USD

Based on the latest financial reports, Sansure Biotech Inc (688289) has total liabilities worth CN¥2.56 Billion CNY (≈ $374.89 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Sansure Biotech Inc asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Sansure Biotech Inc - Total Liabilities Trend (2017–2025)

This chart illustrates how Sansure Biotech Inc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see 688289 total assets.

Sansure Biotech Inc Competitors by Total Liabilities

The table below lists competitors of Sansure Biotech Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Better Life Commercial Chain Share Co Ltd SHE:002251	China	CN¥13.44 Billion
Parade Technologies Ltd TWO:4966	Taiwan	NT$3.64 Billion
Clearway Energy Inc NYSE:CWEN-A	USA	$11.36 Billion
PM Capital Global Opportunities Fund Ltd AU:PGF	Australia	AU$364.24 Million
Central Plaza Hotel Public Company Limited BK:CENTEL-R	Thailand	฿39.97 Billion
Arlo Technologies NYSE:ARLO	USA	$216.06 Million
Neway CNC Equipment Suzhou Co Ltd SHG:688697	China	CN¥3.05 Billion
Wolverine World Wide Inc NYSE:WWW	USA	$1.21 Billion

Liability Composition Analysis (2017–2025)

This chart breaks down Sansure Biotech Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Sansure Biotech Inc balance sheet quality to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	4.67	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.37	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.27	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Sansure Biotech Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Sansure Biotech Inc (2017–2025)

The table below shows the annual total liabilities of Sansure Biotech Inc from 2017 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥-7.22 Billion ≈ $-1.06 Billion	-673.93%
2024-12-31	CN¥1.26 Billion ≈ $184.09 Million	+22.22%
2023-12-31	CN¥1.03 Billion ≈ $150.62 Million	-38.03%
2022-12-31	CN¥1.66 Billion ≈ $243.05 Million	+134.26%
2021-12-31	CN¥709.03 Million ≈ $103.75 Million	+0.01%
2020-12-31	CN¥708.95 Million ≈ $103.74 Million	+734.17%
2019-12-31	CN¥84.99 Million ≈ $12.44 Million	-45.43%
2018-12-31	CN¥155.76 Million ≈ $22.79 Million	-16.54%
2017-12-31	CN¥186.62 Million ≈ $27.31 Million	--

About Sansure Biotech Inc

SHG:688289 China Medical Instruments & Supplies

Market Cap

$1.40 Billion

CN¥9.56 Billion CNY

Market Cap Rank

#7580 Global

#1687 in China

Share Price

CN¥16.63

Change (1 day)

+0.60%

52-Week Range

CN¥13.87 - CN¥22.12

All Time High

CN¥81.40